| +0.04 / +0.30%|
The 5 analysts offering 12-month price forecasts for Insmed Inc have a median target of 25.00, with a high estimate of 51.00 and a low estimate of 20.00. The median estimate represents a +89.11% increase from the last price of 13.22.
The current consensus among 5 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.